Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Firefly Neuroscience (AIFF) over the last 13 years, with Q3 2025 value amounting to 0.89%.

  • Firefly Neuroscience's Return on Capital Employed rose 37200.0% to 0.89% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.89%, marking a year-over-year increase of 37200.0%. This contributed to the annual value of 7.42% for FY2024, which is 85300.0% up from last year.
  • Latest data reveals that Firefly Neuroscience reported Return on Capital Employed of 0.89% as of Q3 2025, which was up 37200.0% from 1.05% recorded in Q2 2025.
  • Firefly Neuroscience's Return on Capital Employed's 5-year high stood at 502.7% during Q4 2024, with a 5-year trough of 8.46% in Q1 2025.
  • In the last 5 years, Firefly Neuroscience's Return on Capital Employed had a median value of 0.64% in 2022 and averaged 25.08%.
  • As far as peak fluctuations go, Firefly Neuroscience's Return on Capital Employed skyrocketed by 5045900bps in 2024, and later plummeted by -60400bps in 2025.
  • Over the past 5 years, Firefly Neuroscience's Return on Capital Employed (Quarter) stood at 0.18% in 2021, then tumbled by -254bps to 0.64% in 2022, then plummeted by -192bps to 1.89% in 2023, then skyrocketed by 26768bps to 502.7% in 2024, then plummeted by -100bps to 0.89% in 2025.
  • Its Return on Capital Employed stands at 0.89% for Q3 2025, versus 1.05% for Q2 2025 and 8.46% for Q1 2025.